JD-SW
09618
XIAOMI-W
01810
BEKE-W
02423
ALI HEALTH
00241
BABA-W
09988
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q9)Dec 31, 2023 | (Q6)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q3)Jun 30, 2022 | (FY)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -7.66%6.92M | 1.39%16.87M | -1.50%9.31M | -10.83%7.49M | -16.86%1.82M | -0.75%16.64M | -7.85%9.45M | -3.97%8.4M | 7.87%2.19M | 4.61%16.76M |
Operating income | -7.66%6.92M | 1.39%16.87M | -1.50%9.31M | -10.83%7.49M | -16.86%1.82M | -0.75%16.64M | -7.85%9.45M | -3.97%8.4M | 7.87%2.19M | 4.61%16.76M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | 19.99%-1.41M | -2.07%-2.81M | -0.35%-2.29M | -12.27%-1.77M | -52.10%-940K | -1.14%-2.76M | -6.14%-2.28M | -4.17%-1.57M | -11.15%-618K | -8.92%-2.72M |
Employee expense | -2.26%-6.35M | -0.64%-12.6M | -1.13%-9.56M | -7.46%-6.21M | 1.64%-2.87M | -11.03%-12.52M | -21.72%-9.46M | -13.70%-5.78M | -15.22%-2.92M | -22.37%-11.28M |
Revaluation surplus | 255.63%498K | ---- | ---- | 87.50%-320K | ---- | ---- | -1,645.97%-2.17M | -734.20%-2.56M | ---- | -113.43%-409K |
-Changes in the fair value of financial assets | 255.63%498K | ---- | ---- | 87.50%-320K | ---- | ---- | -1,645.97%-2.17M | -734.20%-2.56M | ---- | -113.43%-409K |
Impairment and provision | ---- | -45.19%171K | ---- | ---- | ---- | 164.86%312K | ---- | ---- | ---- | -284.80%-481K |
-Other impairment is provision | ---- | -45.19%171K | ---- | ---- | ---- | 164.86%312K | ---- | ---- | ---- | -284.80%-481K |
Special items of operating profit | 78.14%-922K | 31.46%-7.15M | 28.73%-3.62M | 33.35%-4.22M | 65.70%-1.77M | -68.45%-10.43M | 4.64%-5.08M | -55.12%-6.33M | -253.05%-5.15M | -4,492.20%-6.19M |
Operating profit | 74.72%-1.27M | 36.93%-5.53M | 35.32%-6.17M | 35.94%-5.02M | 42.17%-3.76M | -102.66%-8.76M | -86.34%-9.54M | -251.30%-7.84M | -158.12%-6.5M | -158.85%-4.32M |
Financing cost | -72.73%-57K | -136.54%-246K | 64.49%-49K | 65.98%-33K | 5.56%-17K | 21.80%-104K | -15.00%-138K | -21.25%-97K | 48.57%-18K | 18.40%-133K |
Earning before tax | 73.75%-1.33M | 34.89%-5.77M | 35.74%-6.22M | 36.31%-5.06M | 42.07%-3.77M | -98.95%-8.87M | -84.70%-9.67M | -295.91%-7.94M | -155.29%-6.52M | -162.04%-4.46M |
Tax | -438.89%-97K | 25.71%-104K | 61.96%-62K | 73.53%-18K | 68.75%-10K | -45.83%-140K | -63.00%-163K | -70.00%-68K | -10.34%-32K | 42.86%-96K |
After-tax profit from continuing operations | 71.94%-1.42M | 34.75%-5.88M | 36.17%-6.28M | 36.62%-5.07M | 42.20%-3.78M | -97.83%-9.01M | -84.30%-9.84M | -291.49%-8.01M | -153.66%-6.55M | -164.89%-4.55M |
Earning after tax | 71.94%-1.42M | 34.75%-5.88M | 36.17%-6.28M | 36.62%-5.07M | 42.20%-3.78M | -97.83%-9.01M | -84.30%-9.84M | -291.49%-8.01M | -153.66%-6.55M | -164.89%-4.55M |
Minority profit | 105.77%428K | -45.21%469K | -19.05%459K | -43.63%208K | -50.95%180K | 43.62%856K | 103.23%567K | 99.46%369K | 39.02%367K | -38.81%596K |
Profit attributable to shareholders | 64.94%-1.85M | 35.66%-6.35M | 35.24%-6.74M | 36.93%-5.28M | 42.67%-3.96M | -91.55%-9.86M | -85.24%-10.4M | -275.56%-8.38M | -143.02%-6.91M | -185.22%-5.15M |
Basic earnings per share | 75.86%-0.0007 | 35.71%-0.0036 | 38.98%-0.0036 | 39.58%-0.0029 | 43.59%-0.0022 | -93.10%-0.0056 | -84.38%-0.0059 | -269.23%-0.0048 | -143.75%-0.0039 | -182.86%-0.0029 |
Diluted earnings per share | 75.86%-0.0007 | 35.71%-0.0036 | 38.98%-0.0036 | 39.58%-0.0029 | 43.59%-0.0022 | -93.10%-0.0056 | -84.38%-0.0059 | -269.23%-0.0048 | -143.75%-0.0039 | -182.86%-0.0029 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Yongtuo Fuxin Certified Public Accountants Co., Ltd. | -- | -- | -- | Grant Thornton (Hong Kong) Certified Public Accountants | -- | -- | -- | Grant Thornton (Hong Kong) Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Unlock the Full List